Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001387131-14-003669
Filing Date
2014-11-10
Accepted
2014-11-10 17:24:48
Documents
1
Period of Report
2014-11-07

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT denby-form4_110714.html 4  
1 OWNERSHIP DOCUMENT denby-form4_110714.xml 4 4137
  Complete submission text file 0001387131-14-003669.txt   5800
Mailing Address 11455 EL CAMINO REAL SUITE 310 SAN DIEGO CA 92130
Business Address 11455 EL CAMINO REAL SUITE 310 SAN DIEGO CA 92130 (858) 997-2400
Adamis Pharmaceuticals Corp (Issuer) CIK: 0000887247 (see all company filings)

EIN.: 820429727 | State of Incorp.: DE | Fiscal Year End: 0331
SIC: 2834 Pharmaceutical Preparations

Mailing Address
Business Address 10590 W OCEAN AIR DR STE 200 SAN DIEGO CA 92130 8583145700
DENBY WILLIAM C (Reporting) CIK: 0001279193 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-36242 | Film No.: 141209918
SIC: 2834 Pharmaceutical Preparations